On November 30, 2020 Oasmia Pharmaceutical reported that it will publish its interim report for the second quarter of 2020 on December 9, 2020, at 08.00 am CET (Press release, Oasmia, NOV 30, 2020, View Source [SID1234571972]). The company will hold a conference call and an online presentation on the same day at 10.00 am CET. The call will be hosted by CEO Francois Martelet and Acting CFO Robert Maiorana. The presentation will be in English.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!